BiomarkersHuman trial
The Addition of the AHA PREVENT Risk Model to NT-proBNP–Based Screening in Patients with Diabetes and Risk Factors for Heart Failure: An Exploratory Analysis of TARTAN-HF
ADA Scientific Sessions 2026 Abstract
The paper
TAYLOR-SWEET DR, PETRIE M, MCKINLEY G et al.
ADA Scientific Sessions 2026 Abstract · 5 Jun 2026
Presented at ADA Scientific Sessions 2026 · Late-breaking 2973-LB
